T. Ho

Nontuberculous mycobacterial pulmonary infection in renal transplant recipients

E. Coche, J. Yombi, N. Kanaan, 2010, Transplant infectious disease : an official journal of the Transplantation Society.

Limited Performance of Estimated Total Kidney Volume for Follow-up of ADPKD

N. Michoux, Y. Pirson, L. Annet, 2021, Kidney international reports.

Limited performance of estimated total kidney volume for follow-up of autosomal dominant polycystic kidney disease

N. Michoux, Y. Pirson, L. Annet, 2021 .

Autosomal dominant polycystic kidney disease is associated with central and nephrogenic defects in osmoregulation.

J. Haymann, A. Serra, O. Devuyst, 2012, Kidney international.

Lanreotide Reduces Liver Volume, But Might Not Improve Muscle Wasting or Weight Loss, in Patients With Symptomatic Polycystic Liver Disease.

F. Dobbels, F. Nevens, B. Bammens, 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Development and validation of a polycystic liver disease complaint-specific assessment (POLCA).

F. Dobbels, F. Nevens, B. Bammens, 2014, Journal of hepatology.

Safety and efficacy of different lanreotide doses in the treatment of polycystic liver disease: pooled analysis of individual patient data

F. Nevens, B. Bammens, R. Vanslembrouck, 2013, Alimentary pharmacology & therapeutics.

Safety and ef fi cacy of different lanreotide doses in the treatment of polycystic liver disease : pooled analysis of individual patient data

F. Nevens, B. Bammens, R. Vanslembrouck, 2013 .

Night blindness in a haemodialysed ADPKD patient receiving octreotide

Y. Pirson, T. Ho, P. Decleire, 2012, Clinical kidney journal.

Urinary Biomarkers at Early ADPKD Disease Stage

A. Serra, D. Poster, F. Krauer, 2015, PloS one.

Calcineurin Inhibitors Downregulate HNF-1&bgr; and May Affect the Outcome of HNF1B Patients After Renal Transplantation

N. Chassaing, J. Schanstra, L. Rostaing, 2016, Transplantation.